There are huge variations of individual patients of diabetes especially diabetes II, and the complications of diabetes are different, so it is very important to medicate personalized in diabetes treatment.

The shortness of traditional and empirical medication is none personalization. Those patients with poor healing efficiency have to try other medicines to gradually change the healthy conditions. Human bodies show different sensitivity to different medicines. Some of them are good for one but could be fatal side effects in some patients with special genotypes. Due to the special genotypes, some of patients are resisting to some medicines and need large dose of medicine to gain the effects but if it is sensitive to some medicines, small dose will be effective.

UG diabetes personalized medical products contains the genotyping of medicine metabolic related genes. The testing results could be related to the healing efficiency or be able to identify poor metabolizer, extensive metabolizer or super metabolizer. By combination of the testing results and other symptoms or physiological conditions, personalized medication advice is provided to instruct the diabetes treatment that decreases the hazard to human body as much as possible.

For now, the product aims at the efficiency testing of antidiabetic drugs of sulfonylureas, such as glibenclamide, glipizide, gliclazide, glibornuride, gliquidone, and so on.